| Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients FC Barreto, DV Barreto, S Liabeuf, N Meert, G Glorieux, M Temmar, ... Clinical Journal of the American Society of Nephrology 4 (10), 1551-1558, 2009 | 946 | 2009 |
| Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease S Liabeuf, DV Barreto, FC Barreto, N Meert, G Glorieux, E Schepers, ... Nephrology Dialysis Transplantation 25 (4), 1183-1191, 2010 | 470 | 2010 |
| Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease DV Barreto, FC Barreto, S Liabeuf, M Temmar, HD Lemke, C Tribouilloy, ... Kidney international 77 (6), 550-556, 2010 | 374 | 2010 |
| The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report LJ Schurgers, DV Barreto, FC Barreto, S Liabeuf, C Renard, ... Clinical journal of the American society of nephrology 5 (4), 568-575, 2010 | 364 | 2010 |
| K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients FC Barreto, DV Barreto, RMA Moyses, KR Neves, MEF Canziani, ... Kidney international 73 (6), 771-777, 2008 | 294 | 2008 |
| Enzyme replacement therapy for Anderson‐Fabry disease R El Dib, H Gomaa, RP Carvalho, SE Camargo, R Bazan, P Barretti, ... Cochrane Database of Systematic Reviews, 2016 | 238 | 2016 |
| Vitamin D affects survival independently of vascular calcification in chronic kidney disease DV Barreto, FC Barreto, S Liabeuf, M Temmar, F Boitte, G Choukroun, ... Clinical journal of the American Society of Nephrology 4 (6), 1128-1135, 2009 | 214 | 2009 |
| Phosphate binder impact on bone remodeling and coronary calcification–results from the BRiC study DV Barreto, FC Barreto, AB De Carvalho, L Cuppari, SA Draibe, ... Nephron Clinical Practice 110 (4), c273-c283, 2008 | 212 | 2008 |
| Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors DV Barreto, FC Barreto, AB Carvalho, L Cuppari, M Cendoroglo, ... Kidney international 67 (4), 1576-1582, 2005 | 203 | 2005 |
| Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease E Schepers, DV Barreto, S Liabeuf, G Glorieux, S Eloot, FC Barreto, ... Clinical Journal of the American Society of Nephrology 6 (10), 2374-2383, 2011 | 171 | 2011 |
| The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease FG Graciolli, KR Neves, F Barreto, DV Barreto, LM Dos Reis, ME Canziani, ... Kidney international 91 (6), 1436-1446, 2017 | 165 | 2017 |
| Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study DV Barreto, F de Carvalho Barreto, AB de Carvalho, L Cuppari, SA Draibe, ... American Journal of Kidney Diseases 52 (6), 1139-1150, 2008 | 157 | 2008 |
| Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem FC Barreto, DV Barreto, RMA Moyses, CL Neves, V Jorgetti, SA Draibe, ... Kidney international 69 (10), 1852-1857, 2006 | 134 | 2006 |
| Strategies for phosphate control in patients with CKD FC Barreto, DV Barreto, ZA Massy, TB Drüeke Kidney international reports 4 (8), 1043-1056, 2019 | 116 | 2019 |
| The impact of type 2 diabetes on bone metabolism CP Sanches, AGD Vianna, FC Barreto Diabetology & Metabolic Syndrome 9, 1-7, 2017 | 108 | 2017 |
| Effects of phosphate on vascular function under normal conditions and influence of the uraemic state I Six, J Maizel, FC Barreto, AY Rangrez, S Dupont, M Slama, C Tribouilloy, ... Cardiovascular research 96 (1), 130-139, 2012 | 105 | 2012 |
| Enzyme replacement therapy for Anderson-Fabry disease: a complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from … R El Dib, H Gomaa, A Ortiz, J Politei, A Kapoor, F Barreto PloS one 12 (3), e0173358, 2017 | 99 | 2017 |
| Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins S Eloot, E Schepers, DV Barreto, FC Barreto, S Liabeuf, W Van Biesen, ... Clinical Journal of the American Society of Nephrology 6 (6), 1266-1273, 2011 | 97 | 2011 |
| Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate ALE Cancela, RB Oliveira, FG Graciolli, LM Dos Reis, F Barreto, ... Nephron Clinical Practice 117 (1), c74-c82, 2010 | 94 | 2010 |
| The renal osteodystrophy pattern in Brazil and Uruguay: an overview SMHA Araújo, P Ambrosoni, RRS Lobão, H Caorsi, RMA Moysés, ... Kidney International 63, S54-S56, 2003 | 88 | 2003 |
Vanda JorgettiFaculdade de Medicina - Universidade de São PauloVerified email at usp.br
